Cardiac Rhythm Management Devices | BRIC | 2014 | Market Analysis
The BRIC market for CRM devices will experience robust growth through 2022, driven primarily by rising use of this technology to treat arrhythmia and heart failure, as well as by the growing economies in the region.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CRMdevices in BRIC across a 10-year period.